Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_assertion type Assertion NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_head.
- NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_assertion description "[We screened for the most common LRRK 2 mutation in a series of patients with Parkinson's Disease, Alzheimer's disease, Progressive Supranuclear Palsy, Multiple System Atrophy and frontotemporal dementia, as well as in neurologically normal controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_provenance.
- NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_assertion evidence source_evidence_literature NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_provenance.
- NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_assertion SIO_000772 16102903 NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_provenance.
- NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_assertion wasDerivedFrom gad-20150221 NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_provenance.
- NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_assertion wasGeneratedBy ECO_0000203 NP94927.RAkC3q0nTv8SXn66_FF-j9GG2dpAN9IyGnWqRxmZTpqcc130_provenance.